Search

Learn what Zepbound, Wegovy, Ozempic and other weight loss drugs mean for cancer risk and treatment, from an expert at MSK.

… Tuesday, March 10, 2026 Ozempic, Zepbound, Wegovy, and related weight loss drugs have become some of the world’s most talked about medications in a remarkably short time. A growing body of research suggests these drugs may also be an important tool in reducing cancer related to obesity and higher levels

Discover how microbiome research is revealing the role that bacteria play in cancer treatment.

… Thursday, August 11, 2016 Summary Studies that analyze the microbiome — the community of organisms that live in the body — in cancer patients are revealing new findings about the connection between bacteria and health in cancer patients. Highlights One study has shown how microbes may trigger colitis

For men with inherited mutations in BRCA1 and BRCA2, a new program at MSK provides a “one-stop shop” for highly personalized cancer screening and surveillance.

… Thursday, June 16, 2022 Perhaps the best known of all the cancer predisposition genes are inherited mutations in the genes BRCA1 and BRCA2 . They were originally associated with an increased risk of breast and ovarian cancers . Later studies revealed they also raised the risk of prostate and pancreatic

Researchers discover that a subset of lung adenocarcinomas are aggressive because of mutations that allow them to block ferroptosis, a type of cell death.

… Tuesday, December 1, 2020 Summary An MSK team has found that a particular subset of lung adenocarcinomas is aggressive due to a combination of two mutations that allow them to block ferroptosis, a type of cell death. Targeted therapies are currently available for about one-third of people with lung adenocarcinoma

In our recently published review paper we provide a comprehensive update on the cardiotoxicities associated with contemporary breast cancer treatment and the latest strategies for their prevention, detection, and management.

… Friday, June 28, 2019 It is critical to balance the expected benefits of cancer treatment with cardiovascular risk and identify strategies to prevent cardiotoxicity and improve outcomes and the long-term quality of life for breast cancer survivors. In our review paper published recently in the journal

When considering adjuvant therapy preferences for younger patients ages 50 to 69 with early-stage, low genomic risk breast cancer, is it reasonable to omit radiotherapy or endocrine therapy after lumpectomy? A large retrospective cohort study at MSK found that locoregional recurrence rates were significantly lower for those who completed at least one form of adjuvant therapy after lumpectomy.

… Friday, October 10, 2025 When considering adjuvant therapy preferences for younger patients ages 50 to 69 with early-stage, low genomic risk breast cancer, is it reasonable to omit radiotherapy (RT) or endocrine therapy (ET) after lumpectomy? A large retrospective cohort study at MSK found that locoregional

Wider negative margins do not improve local control for ductal carcinoma in situ or invasive carcinoma when they are treated with lumpectomy and radiation therapy, our recent literature review shows.

… Monday, October 8, 2018 Wider negative margins do not improve local control for ductal carcinoma in situ or invasive carcinoma when they are treated with lumpectomy and radiation therapy, our recent literature review shows. However, ambiguity regarding margin width in such cases persists, leading to

Memorial Sloan Kettering Cancer Center, along with five other elite academic institutions, will share an unprecedented total of $540 million in new financial support from Ludwig Cancer Research.

… Monday, January 6, 2014 Ludwig Center at Memorial Sloan Kettering Receives $90 Million in Funding For Cancer Research Memorial Sloan Kettering Cancer Center, along with five other elite academic institutions, will share an unprecedented total of $540 million in new financial support from Ludwig Cancer

MSK experts discuss risk factors, symptoms, and treatment for male breast cancer.

… Monday, September 26, 2022 Breast cancer in men accounts for less than 1% of all cases of breast cancer . But because breast cancer is so common, that still amounts to about 2,700 cases in the United States every year. The current treatments for men with breast cancer are largely based on what doctors

Sequencing advanced endometrial tumors with the MSK-IMPACT™ assay provides an effective method for detecting microsatellite instability (MSI) and germline cancer predisposition syndromes

… Thursday, December 13, 2018 Sequencing advanced endometrial tumors with the MSK-IMPACT™ assay provides an effective method for detecting microsatellite instability (MSI) and germline cancer predisposition syndromes, which are collectively present in 16 percent of patients, as well as potentially actionable